171234 20260515163946.0 doi 10.1136/bjo.2010.193078 sideral 149300 ART-2011-149300 eng Garcia-Martin, E. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma 2011 Background To compare the efficacy, cosmesis and tolerance of two non-surgical treatments—imiquimod (IMQ) 5% cream and radiotherapy (RT)—to combat periocular nodular basal cell carcinoma (BCC). Methods Twenty-seven patients with clinical and histopathological diagnosis of nodular BCC on the eyelid were included and randomly selected: 15 patients were treated with IMQ 5% cream once daily, 5 days/week for 6 weeks, and 12 patients were treated with RT. Results All tumours showed histopathological remission within 3 months of the treatment, and sustained clinical remission was documented in each patient after 24 months' follow-up. Treatment tolerability was rated as moderate with IMQ and good with RT. Functional results were better in patients treated with IMQ. Loss of eyelashes was reported for most of the patients treated with RT. Conclusions IMQ and RT therapies are effective for treating eyelid nodular BCCs. Cosmesis and functional results were better with IMQ, while tolerability was higher with RT. info:eu-repo/semantics/closedAccess All rights reserved http://www.europeana.eu/rights/rr-f/ 2.902 2011 OPHTHALMOLOGY 10 / 58 = 0.172 2011 Q1 T1 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Gil-Arribas, L. M. Idoipe, M. Alfaro, J. Pueyo, V. Universidad de Zaragoza (orcid)0000-0002-1777-0349 Pablo, L. E. Fernandez, F. J. 1004 646 Universidad de Zaragoza Dpto. Cirugía,Ginecol.Obstetr. Área Oftalmología 95, 10 (2011), 1393-1396 Br. j. ophthalmol. British Journal of Ophthalmology 0007-1161 355137 http://zaguan.unizar.es/record/171234/files/texto_completo.pdf Versión publicada 3122406 http://zaguan.unizar.es/record/171234/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:171234 articulos driver 2026-05-15-14:55:39 ARTICLE